uhs-8k_20170425.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 25, 2017

 

UNIVERSAL HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

 

DELAWARE

 

1-10765

 

23-2077891

(State or other jurisdiction of

 

(Commission

 

(I.R.S. Employer

Incorporation or Organization)

 

File Number)

 

Identification No.)

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, PENNSYLVANIA 19406

(Address of principal executive office) (Zip Code)

Registrant’s telephone number, including area code (610) 768-3300

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 


 

Item 2.02 Results of Operations and Financial Condition

On April 25, 2017, Universal Health Services, Inc. issued the press release attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. 99.1 Universal Health Services, Inc., press release, dated April 25, 2017.

 

 

 


 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Universal Health Services, Inc.

 

By:

 

/s/ Steve Filton

Name: Steve Filton

Title: Executive Vice President and

            Chief Financial Officer

Date: April 25, 2017

 

 

 


 

Exhibit Index

 

Exhibit No.

  

Exhibit

 

 

99.1

  

Universal Health Services, Inc., press release, dated April 25, 2017.

 

 

uhs-ex991_6.htm

Exhibit 99.1

FOR IMMEDIATE RELEASE

 

CONTACT:Steve Filton

Chief Financial OfficerApril 25, 2017

610-768-3300

 

 

UNIVERSAL HEALTH SERVICES, INC.

REPORTS 2017 FIRST QUARTER FINANCIAL RESULTS

 

Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended March 31, 2017 and 2016:

KING OF PRUSSIA, PA – Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $206.1 million, or $2.12 per diluted share, during the first quarter of 2017 as compared to $190.8 million, or $1.93 per diluted share, during the comparable quarter of 2016.  

 

Net revenues increased 6.7% to $2.61 billion during the first quarter of 2017 as compared to $2.45 billion during the first quarter of 2016. As calculated on attached Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), our earnings before interest, taxes, depreciation & amortization (“EBITDA”) increased 5.7% to $460.3 million during the first quarter of 2017 as compared to $435.4 million during the first quarter of 2016.

 

For the three-month period ended March 31, 2017, our adjusted net income attributable to UHS, as calculated on the attached Supplemental Schedule, increased to $204.4 million, or $2.10 per diluted share, as compared to $196.0 million, or $1.98 per diluted share, during the first quarter of 2016.  As reflected on the Supplemental Schedule, included in our reported results during the first quarter of 2017, is a favorable after-tax impact of $6.8 million, or $.07 per diluted share, related to our January 1, 2017 adoption of ASU 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting” (“ASU 2016-09”), as discussed below.  Also included in our reported results were the unfavorable after-tax impacts of $5.1 million, or $.05 per diluted share, during the first quarter of 2017 and $5.2 million, or $.05 per diluted share, during the first quarter of 2016, related to the depreciation and amortization expense recorded in connection with the implementation of electronic health records (“EHR”) applications at our acute care hospitals.

 

Acute Care Services – Three-month periods ended March 31, 2017 and 2016:

During the first quarter of 2017, at our acute care hospitals owned during both periods (“same facility basis”), adjusted admissions (adjusted for outpatient activity) increased 5.1% and adjusted patient days increased 1.7%, as compared to the first quarter of 2016. Net revenues from our acute care services increased 4.8% during the first quarter of 2017 as compared to the first quarter of the prior year. At these facilities, net revenue per adjusted admission decreased 0.4% while net revenue per adjusted patient day increased 3.0% during the first quarter of 2017 as compared to the comparable quarter of 2016. On a same facility basis, the operating margin generated from our acute care services was 19.7% during the first quarter of 2017 as compared to 21.1% during the first quarter of 2016. We define operating margin as net revenues less salaries, wages and benefits, other operating expenses and supplies expense, divided by net revenues (excluding the impact of EHR).

 

We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on gross charges, amounting to approximately $416 million and $345 million during the three-month periods ended March 31, 2017 and 2016,


respectively. The provision for doubtful accounts at our acute care hospitals amounted to approximately $181 million and $140 million during the three-month periods ended March 31, 2017 and 2016.          

 

Behavioral Health Care Services – Three-month periods ended March 31, 2017 and 2016:

During the first quarter of 2017, at our behavioral health care facilities on a same facility basis, adjusted admissions increased 2.4% while adjusted patient days increased 0.2% as compared to the first quarter of 2016. At these facilities, net revenue per adjusted admission decreased 1.1% while net revenue per adjusted patient day increased 1.1% during the first quarter of 2017 as compared to the comparable quarter in 2016. On a same facility basis, our behavioral health care services’ net revenues increased 1.4% during the first quarter of 2017, as compared to the first quarter of 2016, and the operating margins were 25.6% and 27.5% during the first quarters of 2017 and 2016, respectively.  

 

Update on the Review by The Competition and Markets Authority (“CMA”) of Our December, 2016 Acquisition of Cambian Group, PLC’s Adult Services’ Division:

Late last week the CMA notified us that they have identified potential competition concerns in certain markets and announced its decision to refer our acquisition of Cambian Group, PLC’s Adult Services division for a Phase 2 investigation unless we offer acceptable undertakings to address their concerns. The deadline to propose potential undertakings is April 28, 2017 and the CMA has until May 8, 2017 to accept or reject our proposed undertakings.

 

Share Repurchase Program:

In February of 2016, our Board of Directors authorized a $400 million increase to our stock repurchase program, which increased the aggregate authorization to $800 million from the previous $400 million authorization approved during the third quarter of 2014.  Pursuant to this program, we may purchase shares of our Class B Common Stock, from time to time as conditions allow, on the open market or in negotiated private transactions.  

 

In conjunction with this program, during the first quarter of 2017, we have repurchased 103,948 shares at an aggregate cost of $11.2 million (approximately $108 per share).  Since inception of the program through March 31, 2017, we have repurchased approximately 4.49 million shares at an aggregate cost of approximately $525.3 million (approximately $117 per share).  

 

Adoption of ASU 2016-09:

Effective January 1, 2017, we adopted ASU 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting”, which amends the accounting for employee share-based payment transactions to require recognition of the tax effects resulting from the settlement of stock-based awards as income tax expense or benefit in the income statement in the reporting period in which they occur.  In connection with the adoption of ASU 2016-09, during the first quarter of 2017, we recorded a $6.8 million reduction to our provision for income taxes which resulted in an increase of $6.8 million, or $.07 per diluted share, in net income attributable to UHS.

 

Since the impact of ASU 2016-09 on our future financial statements is dependent upon the timing of stock option exercises, and the market price of our stock at the time of exercise, we are unable to estimate the impact this adoption will have on our future provision for income taxes and net income attributable to UHS.  This reporting change is applied prospectively, effective as of January 1, 2017, with the exception of the change in the presentation of the excess income tax benefits related to stock-based compensation in the Statement of Cash Flows, which was applied retrospectively.    

 

Conference call information:        

We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on Wednesday, April 26, 2017. The dial-in number is 1-877-648-7971.  


A live broadcast of the conference call will be available on our website at www.uhsinc.com.  A replay of the call will be available following the conclusion of the live call and will be available for one full year.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Services, Inc. (“UHS”) is one of the nation’s largest hospital companies operating through its subsidiaries acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands.  It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT).  For additional information on the Company, visit our web site: http://www.uhsinc.com.

 

This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk Factors in our Form 10-K for the year ended December 31, 2016), may cause the results to differ materially from those anticipated in the forward-looking statements.  Many of the factors that will determine our future results are beyond our capability to control or predict. These statements are subject to risks and uncertainties and therefore actual results may differ materially.  Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof.  We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

 

We believe that operating income, operating margin, adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA and adjusted EBITDA, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are nonrecurring or non-operational in nature including, but not limited to, costs/benefits related to the impact on our provision for income taxes and net income attributable to UHS resulting from our January 1, 2017 adoption of ASU 2016-09, the implementation of EHR applications at our acute care hospitals, extinguishment of debt, gains/losses on sales of assets and businesses, reserves for settlements, legal judgments and lawsuits, impairments of long-lived assets, and other items and other material amounts that may be reflected in the current or prior year financial statements that relate to prior periods.  

 

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2016. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

 

 

(more)


Universal Health Services, Inc.

 

Consolidated Statements of Income

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Three months

 

 

 

ended March 31,

 

 

 

2017

 

 

2016

 

Net revenues before provision for doubtful accounts

 

$

2,825,472

 

 

$

2,619,593

 

Less: Provision for doubtful accounts

 

 

212,614

 

 

 

169,795

 

Net revenues

 

 

2,612,858

 

 

 

2,449,798

 

 

 

 

 

 

 

 

 

 

Operating charges:

 

 

 

 

 

 

 

 

Salaries, wages and benefits

 

 

1,237,964

 

 

 

1,148,139

 

Other operating expenses

 

 

607,360

 

 

 

561,584

 

Supplies expense

 

 

277,614

 

 

 

255,250

 

Depreciation and amortization

 

 

110,798

 

 

 

104,049

 

Lease and rental expense

 

 

25,189

 

 

 

24,452

 

 

 

 

2,258,925

 

 

 

2,093,474

 

Income from operations

 

 

353,933

 

 

 

356,324

 

Interest expense, net

 

 

35,507

 

 

 

29,600

 

Income before income taxes

 

 

318,426

 

 

 

326,724

 

Provision for income taxes

 

 

107,899

 

 

 

111,005

 

Net income

 

 

210,527

 

 

 

215,719

 

Less:  Net income attributable to noncontrolling interests

 

 

4,472

 

 

 

24,960

 

Net income attributable to UHS

 

$

206,055

 

 

$

190,759

 

 

 

 

 

 

 

 

 

 

Basic earnings per share attributable to UHS (a)

 

$

2.13

 

 

$

1.95

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to UHS (a)

 

$

2.12

 

 

$

1.93

 

 



Universal Health Services, Inc.

 

Footnotes to Consolidated Statements of Income

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Three months

 

 

 

ended March 31,

 

 

 

2017

 

 

2016

 

(a) Earnings per share calculation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted:

 

 

 

 

 

 

 

 

Net income attributable to UHS

 

$

206,055

 

 

$

190,759

 

Less: Net income attributable to unvested restricted share grants

 

 

(94

)

 

 

(89

)

Net income attributable to UHS - basic and diluted

 

$

205,961

 

 

$

190,670

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares - basic

 

 

96,585

 

 

 

97,607

 

 

 

 

 

 

 

 

 

 

Basic earnings per share attributable to UHS:

 

$

2.13

 

 

$

1.95

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares

 

 

96,585

 

 

 

97,607

 

Add: Other share equivalents

 

 

787

 

 

 

1,288

 

Weighted average number of common shares and equiv. - diluted

 

 

97,372

 

 

 

98,895

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to UHS:

 

$

2.12

 

 

$

1.93

 

 


Universal Health Services, Inc.

 

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

 

For the three months ended March 31, 2017 and 2016

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA")

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

% Net

 

 

Three months ended

 

 

% Net

 

 

March 31, 2017

 

 

revenues

 

 

March 31, 2016

 

 

revenues

 

Net income attributable to UHS

$

206,055

 

 

 

 

 

 

$

190,759

 

 

 

 

 

   Depreciation and amortization

 

110,798

 

 

 

 

 

 

 

104,049

 

 

 

 

 

   Interest expense, net

 

35,507

 

 

 

 

 

 

 

29,600

 

 

 

 

 

   Provision for income taxes

 

107,899

 

 

 

 

 

 

 

111,005

 

 

 

 

 

Unadjusted EBITDA

$

460,259

 

 

 

17.6

%

 

$

435,413

 

 

 

17.8

%

EHR-related net income attributable to noncontrolling interests, pre-tax

 

(202

)

 

 

 

 

 

 

(962

)

 

 

 

 

Adjusted EBITDA

$

460,057

 

 

 

17.6

%

 

$

434,451

 

 

 

17.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

$

2,612,858

 

 

 

 

 

 

$

2,449,798

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Adjusted Net Income Attributable to UHS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

Three months ended

 

 

March 31, 2017

 

 

March 31, 2016

 

 

 

 

 

 

Per

 

 

 

 

 

 

Per

 

 

Amount

 

 

Diluted Share

 

 

Amount

 

 

Diluted Share

 

Net income attributable to UHS

$

206,055

 

 

$

2.12

 

 

$

190,759

 

 

$

1.93

 

Plus/minus adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impact of ASU 2016-09

 

(6,750

)

 

 

(0.07

)

 

 

-

 

 

 

-

 

After-tax impact of EHR-related items

 

5,073

 

 

 

0.05

 

 

 

5,234

 

 

 

0.05

 

Adjusted net income attributable to UHS

$

204,378

 

 

$

2.10

 

 

$

195,993

 

 

$

1.98

 

 

 

 

 

 


Universal Health Services, Inc.

 

Consolidated Statements of Comprehensive Income

 

(in thousands)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Three months

 

 

 

ended March 31,

 

 

 

2017

 

 

2016

 

Net income

 

$

210,527

 

 

$

215,719

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

Unrealized derivative gains on cash flow hedges

 

 

3,066

 

 

 

(14,299

)

Amortization of terminated hedge

 

 

0

 

 

 

(84

)

Unrealized gain on marketable security

 

 

1,094

 

 

 

0

 

Foreign currency translation adjustment

 

 

7,236

 

 

 

5,986

 

Other comprehensive income before tax

 

 

11,396

 

 

 

(8,397

)

Income tax expense (benefit) related to items of other comprehensive income

 

 

1,551

 

 

 

(5,360

)

Total other comprehensive income (loss), net of tax

 

 

9,845

 

 

 

(3,037

)

 

 

 

 

 

 

 

 

 

Comprehensive income

 

 

220,372

 

 

 

212,682

 

Less: Comprehensive income attributable to noncontrolling interests

 

 

4,472

 

 

 

24,960

 

Comprehensive income attributable to UHS

 

$

215,900

 

 

$

187,722

 

 


Universal Health Services, Inc.

 

Condensed Consolidated Balance Sheets

 

(in thousands)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

 

December 31,

 

 

 

2017

 

 

2016

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

62,974

 

 

$

33,747

 

Accounts receivable, net

 

 

1,447,802

 

 

 

1,439,553

 

Supplies

 

 

126,481

 

 

 

125,365

 

Other current assets

 

 

94,817

 

 

 

82,706

 

Total current assets

 

 

1,732,074

 

 

 

1,681,371

 

Property and equipment

 

 

7,470,405

 

 

 

7,314,437

 

Less: accumulated depreciation

 

 

(3,073,869

)

 

 

(2,983,481

)

 

 

 

4,396,536

 

 

 

4,330,956

 

Other assets:

 

 

 

 

 

 

 

 

Goodwill

 

 

3,787,515

 

 

 

3,784,106

 

Deferred charges

 

 

12,562

 

 

 

13,520

 

Deferred income taxes

 

 

1,255

 

 

 

1,234

 

Other

 

 

518,317

 

 

 

506,615

 

Total Assets

 

$

10,448,259

 

 

$

10,317,802

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Current maturities of long-term debt

 

$

126,064

 

 

$

105,895

 

Accounts payable and accrued liabilities

 

 

1,282,540

 

 

 

1,209,329

 

Federal and state taxes

 

 

108,823

 

 

 

2,149

 

Total current liabilities

 

 

1,517,427

 

 

 

1,317,373

 

 

 

 

 

 

 

 

 

 

Other noncurrent liabilities

 

 

272,680

 

 

 

275,167

 

Long-term debt

 

 

3,772,515

 

 

 

4,030,230

 

Deferred income taxes

 

 

75,468

 

 

 

88,119

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interest

 

 

8,848

 

 

 

9,319

 

 

 

 

 

 

 

 

 

 

UHS common stockholders' equity

 

 

4,735,962

 

 

 

4,533,220

 

Noncontrolling interest

 

 

65,359

 

 

 

64,374

 

Total equity

 

 

4,801,321

 

 

 

4,597,594

 

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Equity

 

$

10,448,259

 

 

$

10,317,802

 

 


Universal Health Services, Inc.

 

Consolidated Statements of Cash Flows

 

(in thousands)

 

(unaudited)

 

 

Three months

 

 

ended March 31,

 

 

2017

 

 

2016

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

 

Net income

$

210,527

 

 

$

215,719

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation & amortization

 

110,798

 

 

 

104,049

 

Stock-based compensation expense

 

15,348

 

 

 

13,204

 

Changes in assets & liabilities, net of effects from acquisitions and dispositions:

 

 

 

 

 

 

 

   Accounts receivable

 

(5,362

)

 

 

(79,962

)

   Accrued interest

 

(6,123

)

 

 

688

 

   Accrued and deferred income taxes

 

102,269

 

 

 

91,131

 

   Other working capital accounts

 

66,877

 

 

 

98,972

 

   Other assets and deferred charges

 

(7,755

)

 

 

(5,803

)

   Other

 

(229

)

 

 

20,911

 

   Excess income tax benefits related to stock-based compensation

 

0

 

 

 

11,002

 

   Accrued insurance expense, net of commercial premiums paid

 

22,007

 

 

 

22,616

 

   Payments made in settlement of self-insurance claims

 

(25,349

)

 

 

(17,298

)

Net cash provided by operating activities

 

483,008

 

 

 

475,229

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

Property and equipment additions, net of disposals

 

(144,338

)

 

 

(127,214

)

Acquisition of property and businesses

 

(17,832

)

 

 

(19,543

)

Increase in capital reserves of commercial insurance subsidiary

 

(3,000

)

 

 

0

 

Costs incurred for purchase and implementation of information technology application

 

(9,456

)

 

 

0

 

Net cash used in investing activities

 

(174,626

)

 

 

(146,757

)

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

Reduction of long-term debt

 

(260,633

)

 

 

(166,671

)

Additional borrowings

 

21,600

 

 

 

14,400

 

Financing costs

 

0

 

 

 

(44

)

Repurchase of common shares

 

(29,167

)

 

 

(171,042

)

Dividends paid

 

(9,662

)

 

 

(9,757

)

Issuance of common stock

 

2,540

 

 

 

2,331

 

Profit distributions to noncontrolling interests

 

(4,118

)

 

 

(3,407

)

Net cash used in financing activities

 

(279,440

)

 

 

(334,190

)

Effect of exchange rate changes on cash and cash equivalents

 

285

 

 

 

(920

)

Increase (decrease) in cash and cash equivalents

 

29,227

 

 

 

(6,638

)

Cash and cash equivalents, beginning of period

 

33,747

 

 

 

61,228

 

Cash and cash equivalents, end of period

$

62,974

 

 

$

54,590

 

Supplemental Disclosures of Cash Flow Information:

 

 

 

 

 

 

 

Interest paid

$

39,404

 

 

$

27,133

 

Income taxes paid, net of refunds

$

5,253

 

 

$

9,093

 

Noncash purchases of property and equipment

$

56,427

 

 

$

47,374

 

 


 

Universal Health Services, Inc.

 

Supplemental Statistical Information

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% Change

 

Same Facility:

 

 

 

 

Quarter ended

 

 

 

 

 

 

3/31/2017

 

Acute Care Services

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

4.8

%

Adjusted Admissions

 

 

 

 

 

5.1

%

Adjusted Patient Days

 

 

 

 

 

1.7

%

Revenue Per Adjusted Admission

 

 

 

 

 

-0.4

%

Revenue Per Adjusted Patient Day

 

 

 

 

 

3.0

%

 

 

 

 

 

 

 

 

Behavioral Health Care Services

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

1.4

%

Adjusted Admissions

 

 

 

 

 

2.4

%

Adjusted Patient Days

 

 

 

 

 

0.2

%

Revenue Per Adjusted Admission

 

 

 

 

 

-1.1

%

Revenue Per Adjusted Patient Day

 

 

 

 

 

1.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

UHS Consolidated

 

 

First quarter ended

 

 

 

 

3/31/2017

 

 

3/31/2016

 

Revenues

 

 

$

2,612,858

 

 

$

2,449,798

 

EBITDA (1)

 

 

$

460,259

 

 

$

435,413

 

EBITDA Margin (1)

 

 

 

17.6

%

 

 

17.8

%

 

 

 

 

 

 

 

 

 

 

Cash Flow From Operations

 

 

$

483,008

 

 

$

475,229

 

Days Sales Outstanding

 

 

 

50

 

 

 

51

 

Capital Expenditures

 

 

$

144,338

 

 

$

127,214

 

 

 

 

 

 

 

 

 

 

 

Debt

 

 

$

3,898,579

 

 

$

3,280,406

 

UHS' Shareholders Equity

 

 

$

4,735,962

 

 

$

4,289,218

 

Debt / Total Capitalization

 

 

 

45.2

%

 

 

43.3

%

Debt / EBITDA (2)

 

 

 

2.32

 

 

 

2.03

 

Debt / Cash From Operations (2)

 

 

 

2.91

 

 

 

2.62

 

 

 

 

 

 

 

 

 

 

 

Acute Care EBITDAR Margin (3)

 

 

 

19.7

%

 

 

21.1

%

Behavioral Health EBITDAR Margin (3)

 

 

 

25.6

%

 

 

27.5

%

 

(1)

Net of Minority Interest

(2)

Latest 4 quarters

(3)

Same facility basis, before Corporate overhead allocation and minority interest.


 

Universal Health Services, Inc.

 

Selected Hospital Statistics

 

For the Three Months ended

 

March 31, 2017 and 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AS REPORTED:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ACUTE

 

 

BEHAVIORAL HEALTH

 

 

 

03/31/17

 

03/31/16

 

% change

 

 

03/31/17

 

03/31/16

 

% change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hospitals owned and leased

 

 

26

 

 

24

 

 

8.3

%

 

 

292

 

 

217

 

 

34.6

%

Average licensed beds

 

 

6,107

 

 

5,854

 

 

4.3

%

 

 

23,056

 

 

21,751

 

 

6.0

%

Patient days

 

 

333,000

 

 

325,171

 

 

2.4

%

 

 

1,592,454

 

 

1,500,705

 

 

6.1

%

Average daily census

 

 

3,700.0

 

 

3,573.5

 

 

3.5

%

 

 

17,693.9

 

 

16,491.3

 

 

7.3

%

Occupancy-licensed beds

 

 

60.6

%

 

61.0

%

 

-0.7

%

 

 

76.7

%

 

75.8

%

 

1.2

%

Admissions

 

 

74,351

 

 

69,674

 

 

6.7

%

 

 

118,330

 

 

115,421

 

 

2.5

%

Length of stay

 

 

4.5

 

 

4.7

 

 

-4.0

%

 

 

13.5

 

 

13.0

 

 

3.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inpatient revenue

 

$

5,597,850

 

$

4,965,537

 

 

12.7

%

 

$

2,183,002

 

$

1,959,570

 

 

11.4

%

Outpatient revenue

 

 

3,294,177

 

 

2,767,329

 

 

19.0

%

 

 

246,460

 

 

221,643

 

 

11.2

%

Total patient revenue

 

 

8,892,027

 

 

7,732,866

 

 

15.0

%

 

 

2,429,462

 

 

2,181,213

 

 

11.4

%

Other revenue

 

 

121,265

 

 

111,557

 

 

8.7

%

 

 

51,476

 

 

50,538

 

 

1.9

%

Gross hospital revenue

 

 

9,013,292

 

 

7,844,423

 

 

14.9

%

 

 

2,480,938

 

 

2,231,751

 

 

11.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total deductions

 

 

7,442,762

 

 

6,417,521

 

 

16.0

%

 

 

1,231,190

 

 

1,040,661

 

 

18.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net hospital revenue before provision for doubtful accounts

 

 

1,570,530

 

 

1,426,902

 

 

10.1

%

 

 

1,249,748

 

 

1,191,090

 

 

4.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for doubtful accounts

 

 

180,983

 

 

139,755

 

 

29.5

%

 

 

31,626

 

 

30,044

 

 

5.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net hospital revenue

 

$

1,389,547

 

$

1,287,147

 

 

8.0

%

 

$

1,218,122

 

$

1,161,046

 

 

4.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SAME FACILITY:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ACUTE (1)

 

 

BEHAVIORAL HEALTH (2)

 

 

 

03/31/17

 

03/31/16

 

% change

 

 

03/31/17

 

03/31/16

 

% change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hospitals owned and leased

 

 

24

 

 

24

 

 

0.0

%

 

 

211

 

 

211

 

 

0.0

%

Average licensed beds

 

 

5,952

 

 

5,854

 

 

1.7

%

 

 

21,758

 

 

21,489

 

 

1.3

%

Patient days

 

 

327,969

 

 

325,171

 

 

0.9

%

 

 

1,493,406

 

 

1,490,216

 

 

0.2

%

Average daily census

 

 

3,644.1

 

 

3,573.5

 

 

2.0

%

 

 

16,593.4

 

 

16,376.0

 

 

1.3

%

Occupancy-licensed beds

 

 

61.2

%

 

61.0

%

 

0.3

%

 

 

76.3

%

 

76.2

%

 

0.1

%

Admissions

 

 

72,652

 

 

69,674

 

 

4.3

%

 

 

117,955

 

 

115,135

 

 

2.4

%

Length of stay

 

 

4.5

 

 

4.7

 

 

-3.3

%

 

 

12.7

 

 

12.9

 

 

-2.2

%

 

(1)

Henderson Hospital and Desert View Hospital are excluded in current year.

(2)

Skywood Recovery and CAMBIAN facilities are excluded in current year.